↑ Grab this Headline Animator

Newbridge Nanotechnology Index NNIX Announces Quarterly Rebalance

i>

Fort Lauderdale, Florida May 25, 2006 -- Newbridge Securities Corporation today announced the quarterly rebalancing and reconstitution of its Newbridge Nanotechnology Index (NYSEArca: NNIX) was executed on May 19, 2006. This quarter saw no additions or deletions among the constituents, leaving the total number of companies included at 24. Constituents subject to the 10% index weight cap were Symyx (NasdaqNM: SMMX) and Headwaters (NYSE: HW). The NNIX ended the quarterly period at 965.52, down 4.7% from the last rebalance on Feb. 16, 2006, but still up 6.0% year-to-date.



The Newbridge Nanotechnology Index (NNIX) has been constructed to track the stock market performance of companies that are currently active in nanotechnology. The Index is comprised of companies whose operations, based on our assessment of products, intellectual property, research initiatives and partnerships, include a significant focus on nanotechnology. Only companies with common stock or ADRs listed on a national market or exchange in the U.S. are eligible. The base date for the Index is June 30, 2004, at which time the base value for the Index was set at 1000. The NNIX is market cap weighted, rebalanced quarterly, and now includes 24 companies.



About Newbridge Securities Corporation

Newbridge is a full-service securities brokerage firm (Member: NASD & SIPC) and a subsidiary of Newbridge Financial, Inc., an integrated financial services company. The Newbridge Institutional Research department specializes in the analysis and coverage of companies that have a strategic focus on nanotechnology. More information is available at our websites www.newbridgereports.com and www.newbridgesecurities.com.



Safe Harbor Statement

This news announcement may contain 's8220;forward-looking statements's8221; within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance and achievements of the company to be materially different from any future results, performance or achievements expressed or implied, such as a difference including, but not limited to, those discussed in Management's8217;s Discussion and Analysis of the Financial Condition and Results of Operation in the Company's8217;s Annual Report on Form 10-K filed by the company with the Securities and Exchange Commission.



For important disclosures please visit: http://www.newbridgesecurities.com/research_rpt_discl.html. Additional information is available upon request. Contact: David M. Keiter, Director of Research, 954-334-3450 x115.

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Mangosteen | Mangosteen Juice | serious illnesses diseases |

---

4933 readers online...

, Local News